NCT06193720 is a NA clinical trial of Arnica montana in Edema, sponsored by Saint-Joseph University.

Who is sponsoring NCT06193720?

NCT06193720 is sponsored by Saint-Joseph University.

What drugs are being tested in NCT06193720?

Interventions in NCT06193720: Arnica montana, Placebo.

What condition does NCT06193720 study?

NCT06193720 studies Edema, Pain, Trismus.

Is NCT06193720 still recruiting?

NCT06193720 is currently completed. Last updated 5 January 2024.

Last reviewed 2024-01-05 · How we verify

NCT06193720

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Arnica Montana Following the Surgical Extraction of Impacted Third Molars

Completed NA Last updated 5 January 2024

What this trial tests

NA trial testing Arnica montana in Edema in 10 participants. Completed in 20 August 2023.

Timeline

3 February 2022

Primary endpoint
20 August 2023

20 August 2023

Quick facts

Lead sponsor	Saint-Joseph University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	10
Start date	3 February 2022
Primary completion	20 August 2023
Estimated completion	20 August 2023
Sites	1 location across Lebanon

Drugs / interventions tested

Arnica montana
Placebo

Conditions studied

Edema — all drugs for Edema →
Pain — all drugs for Pain →
Trismus — all drugs for Trismus →

Sponsor

Saint-Joseph University

Who can join

Adults 16 to 40, any sex, with Edema or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: The aim of this study is to evaluate the action of the homeopathic plant Arnica Montana on postoperative edema, pain and trismus after surgical extraction of impacted wisdom teeth. Materials and Methods: The study is a double-blinded clinical trial recruiting patients undergoing surgical extraction of symmetrically impacted maxillary or mandibular third molars (right and left side). Patients receive alternately and randomly the verum (Arnica Montana 12 CH) or the placebo, in the form of capsules, to be taken 1 day prior to surgery and for 7 days postoperatively. Clinical parameters are collected and include: pain score, maximum mouth opening and facial measurements to assess edema's intensity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Edema

Currently open trials in the same condition.

NCT07033039 — Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre · NA · recruiting
NCT06697470 — Muscle and Subcutaneous Tissue Variation by Ultrasound and Impedance Linked to Fluid Balance in ICU Patients · recruiting
NCT06414759 — Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overlo · Phase 4 · recruiting
NCT05695924 — Surgical Evaluation for Upper Extremity Lymphedema (BioBridge) · NA · recruiting
NCT05505500 — Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. · recruiting

Other Saint-Joseph University trials

Trials by the same sponsor.

NCT07449884 — AI Avatar Video vs. Tell-Show-Do for Reducing Anxiety and Improving Cooperation in Children During Local Anesthesia · NA · recruiting
NCT07350746 — A Comparison of Outcome of Pulpotomy on Immature Permanent Molars Between Different Calcium Silicate-based Materials : a · NA · active not recruiting
NCT07082283 — Short-Term Atrial Pacing and Hemodynamics After Cardiac Surgery · NA · recruiting
NCT07517601 — Erbium-doped Yttrium Aluminum Garnet (Er:YAG) Laser vs Conventional Ceramic Bracket Debonding: A Split-Mouth Clinical Tr · NA · active not recruiting
NCT07525128 — Lateral GBR Using Two Types of Membrane With a Combination of Allograft-xenograft · Phase 4 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06193720 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saint-Joseph University
Last refreshed: 5 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06193720.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing